Dynamic m6A-ncRNAs association and their impact on cancer pathogenesis, immune regulation and therapeutic response
返回论文页
|更新时间:2023-08-29
|
Dynamic m6A-ncRNAs association and their impact on cancer pathogenesis, immune regulation and therapeutic response
Genes & DiseasesVol. 10, Issue 1, (2023)
作者机构:
1. Department of Pharmacy, Xiangya Hospital, Central South University,Hunan,Changsha,China,410008
2. Department of Pathology, Xiangya Hospital, Central South University,Hunan,Changsha,China,410008
3. Department of Pathology, Xiangya Changde Hospital,Hunan,Changde,China,415000
4. National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University,Hunan,Changsha,China,410008
5. Center for Molecular Medicine, Xiangya Hospital, Key Laboratory of Molecular Radiation Oncology of Hunan Province, Central South University,Hunan,Changsha,China,410008
Yuanliang Yan, Jinwu Peng, Qiuju Liang, et al. Dynamic m6A-ncRNAs association and their impact on cancer pathogenesis, immune regulation and therapeutic response. [J]. Genes & Diseases 10(1).(2023)
DOI:
Yuanliang Yan, Jinwu Peng, Qiuju Liang, et al. Dynamic m6A-ncRNAs association and their impact on cancer pathogenesis, immune regulation and therapeutic response. [J]. Genes & Diseases 10(1).(2023) DOI: 10.1016/j.gendis.2021.10.004.
Dynamic m6A-ncRNAs association and their impact on cancer pathogenesis, immune regulation and therapeutic response
摘要
Abstract
Several types of modifications have been proven to participate in the metabolism and processing of different RNA types
including non-coding RNAs (ncRNAs). N-6-methyladenosine (m6A) is a dynamic and reversible RNA modification that is closely involved in the ncRNA homeostasis
and serves as a crucial regulator for multiple cancer-associated signaling pathways. The ncRNAs usually regulate the epigenetic modification
mRNA transcription and other biological processes
displaying enormous roles in human cancers. In this review
we summarized the significant implications of m6A-ncRNA interaction in various types of cancers. In particular
the interplay between m6A and ncRNAs in cancer pathogenesis and therapeutic resistance are being widely recognized. We also discussed the relevance of m6A-ncRNA interaction in immune regulation
followed by the interference on cancer immunotherapeutic procedures. In addition
we briefly highlighted the computation tools that could identify the accurate features of m6A methylome among ncRNAs. In summary
this review would pave the way for a better understanding of the biological functions of m6A-ncRNA crosstalk in cancer research and treatment.